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Abstract  38 
 39 
Programmed Cell Death 4 (PDCD4) protein is a tumour suppressor that inhibits translation through 40 
the mTOR dependent initiation factor EIF4A, but its functional role and mRNA targets in neurons 41 
remain largely unknown. Our work identified that PDCD4 is highly expressed in axons and dendrites 42 
of CNS and PNS neurons, with loss and gain of function experiments in cortical and dorsal root 43 
ganglia primary neurons demonstrating the capacity of PDCD4 to negatively control axonal growth. 44 
To explore PDCD4 transcriptome and translatome targets we used Ribo-Seq and uncovered a list of 45 
potential targets with known functions as axon/neurite outgrowth regulators. In addition, we observed 46 
that PDCD4 can be locally synthesized in adult axons in vivo and its levels decrease at the site of 47 
peripheral nerve injury and before nerve regeneration. Overall, our findings demonstrate that PDCD4 48 
can act as a new regulator of axonal growth via the selective control of translation, providing a target 49 
mechanism for axon regeneration and neuronal plasticity processes in neurons.  50 
 Cold Spring Harbor Laboratory Press on October 5, 2020 - Published by rnajournal.cshlp.orgDownloaded from 
  
3 
 
Main Text 51 
 52 
Introduction 53 
 54 
The tumor suppressor Programmed Cell Death 4 (PDCD4) protein was first described in cancer 55 
studies and has been shown to regulate protein synthesis by inhibition of EIF4A helicase activity 56 
(Yang et al. 2003; Suzuki et al. 2008; Matsuhashi et al. 2019) and via interaction with specific RNA 57 
motives present in a particular subset of target mRNAs (Loh et al. 2009; Wedeken et al. 2011; Biyanee 58 
et al. 2015). In mitogen stimulated cells, the degradation of PDCD4 is necessary for efficient protein 59 
translation, which is a prerequisite for cell growth and proliferation (Dorrello et al. 2006; Schmid et al. 60 
2008). At present, while numerous molecules have been shown to regulate PDCD4, including p21 61 
(Göke et al. 2004), Cdk4 (Jansen et al. 2005) and JNK/c-Jun/AP-1 (Bitomsky et al. 2004; Yang et al. 62 
2003, 2006), there is also a growing list of PDCD4 translational targets, including c-myb, p53, sin1 63 
and bdnf (Singh et al. 2011; Wedeken et al. 2011; Wang et al. 2017; Li et al. 2020), together with 64 
internal ribosome entry site-regulated apoptosis inhibitors (Liwak et al. 2012). Although miss-65 
regulation of PDCD4 in a variety of tumors (Zhang et al. 2006; Gao et al. 2007; Mudduluru et al. 2007; 66 
Zhen et al. 2016) suggests an important role in cancer development (Zhang et al. 2006; Gao et al. 67 
2007; Mudduluru et al. 2007; Zhen et al. 2016), the full scope of PDCD4 translational targets and its 68 
potential role in other growth-dependent cellular systems has only recently started to be elucidated 69 
(Haas et al. 2020). In this regard, the molecular pathways involved in the development of tumor cells 70 
share a significant overlap with axonal growth and regeneration processes in the nervous system, 71 
particularly in the context of protein synthesis regulation (Chédotal et al. 2005; Heine et al. 2015).  72 
 73 
The highly polarized nature that defines the morphology of a neuron makes local protein synthesis in 74 
the different cellular compartments (soma, dendrites and axons) an essential need for their 75 
development and function, being also important for plasticity and regenerative processes in the adult 76 
(Verma et al. 2005; Terenzio et al. 2018; Ohtake et al. 2015; Jiménez-Díaz et al. 2008; Huebner and 77 
Strittmatter 2009; Gumy et al. 2010; Park et al. 2010; Jung et al. 2011; Deglincerti and Jaffrey 2012; 78 
Kar et al. 2013; Obara and Hunt 2014; Sotelo-Silveira and Holt 2014). The acceptance of local protein 79 
translation as a key molecular mechanism in neuronal function has prompted the development of a 80 
variety of experimental models and omics approaches to investigate the specific axonal 81 
transcriptomes and proteomes (reviewed by (Farias et al. 2020). In this context, the elucidation of the 82 
regulatory pathways that can control the selective translation of axonal mRNAs has become an 83 
essential step in the understanding of neuronal development, growth and activity (Swanger and 84 
Bassell 2011; Jung et al. 2012). Among the various molecular mechanisms reported so far (Lin and 85 
Holt 2008; Holt et al. 2019), the mammalian target of rapamycin (mTOR) complex is described as a 86 
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master regulator of local axonal translation and an important signaling process in axonal regeneration 87 
(Verma et al. 2005; Park et al. 2008; Terenzio et al. 2018), while also being affected in many different 88 
tumor types (Murray and Tee 2018). Interestingly, although PDCD4 protein has been described as 89 
an important downstream component of the mTOR pathway, it has not been directly associated with 90 
axonal processes. So far, the function of PDCD4 in the CNS has been linked to fetal alcohol 91 
syndrome, where it regulates general protein synthesis in cortical neurons (Narasimhan et al. 2013; 92 
Riar et al. 2014), and depression like behaviours, via BDNF regulation (Li et al. 2020). In spinal cord 93 
injury PDCD4 has been shown to be downregulated by microRNA-21 (Jiang et al. 2017) reinforcing 94 
the view of its potential role in neuronal mechanisms.   95 
 96 
Considering the reported overlap in the molecular processes that promote both tumor and axon 97 
growth (Chédotal et al. 2005; Heine et al. 2015; Duman-Scheel 2009; Frank and Tsai 2009), we 98 
decided to investigate the potential role of PDCD4 in axonal function and regeneration. We 99 
hypothesized that as a repressor of translation, PDCD4 could be regulating mRNAs involved in axonal 100 
growth, regeneration and/or local protein synthesis and that its expression would be tightly regulated 101 
during these processes. Our study demonstrates how the manipulation of PDCD4 levels in central 102 
and peripheral nervous system neurons can control axonal growth, suggesting a potentially key role 103 
in axon regeneration in vivo. As a way to identify putative mRNAs regulated by PDCD4, we used 104 
ribosome profiling (Ribo-Seq) to explore the translational effects of PDCD4 at a genome wide level. 105 
We detected more than 250 possible mRNAs candidates whose translational efficiency (TE) levels 106 
increase in the absence of PDCD4. Among them we have identified a specific group of genes reported 107 
to be relevant in neurite/axonal development and regeneration. Overall, our findings demonstrate that 108 
PDCD4 can act as a new regulator of axonal growth via the selective control of translational targets, 109 
providing a specific mechanism for axon regeneration and neuronal plasticity processes in neurons. 110 
 111 
Results 112 
 113 
Localization of PDCD4 in the nervous system 114 
To address the role of PDCD4 in neuronal cells, we first investigated its localization across different 115 
neuronal types. As shown in Figure 1A, we could detect PDCD4 protein in the central nervous system 116 
(CNS) of adult rats, both in cell bodies and neurites of CA1 hippocampal, Purkinje and cortical 117 
neurons. PDCD4 is also present in adult axons of the peripheral nervous system (PNS), as 118 
demonstrated following the analysis of its distribution in rat sciatic nerves, where specific axon 119 
detection can be more easily assessed. Crucially, this experimental approach allowed us to precisely 120 
detect high levels of PDCD4 inside the axoplasmic region of both longitudinal and transversal nerve 121 
cryosections (Fig. 1B).  122 
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 123 
Previous work in cancer cells demonstrated that both the translation and activity of PDCD4 can be 124 
regulated via the mTOR-p70S6K pathway (Dorrello et al. 2006), prompting us to investigate the 125 
potential link between PDCD4 and its upstream regulator p70S6K. As shown in Figure 1C, both 126 
PDCD4 and phosphorylated (active) p70S6K-Thr-389 are present in longitudinal sections of ventral 127 
root axons, evidence that activated mTOR pathway co-localizes with PDCD4 in the axoplasm of 128 
peripheral neurons.  129 
 130 
Regulation of PDCD4 levels in primary neurons can control axonal growth 131 
Following the demonstration of PDCD4 expression in CNS and PNS neurons, we decided to explore 132 
its functional role using neuronal in vitro models. First, we used primary cortical neurons isolated from 133 
embryonic mice. These cells can fully differentiate in culture to develop a morphologically intricate 134 
and functionally connected neuronal network after 10-12 days in vitro (Banker 2018; Cotterill et al. 135 
2016). Following this period, axonal growth is decreased to allow the synaptic maturation that leads 136 
to the establishment of a functional network of connected neurons, which is observed after 137 
approximately two weeks in culture (Chiappalone et al. 2006). 138 
 139 
PDCD4 protein was detected in primary cortical neurons throughout their development in culture, with 140 
levels significantly increasing in cell body and axons between days 2 and day 5, and a major  increase 141 
also detected after 12 days in vitro (Fig. 2A). The observation that PDCD4 levels increase in the late 142 
stages of neuronal network development and synaptic maturation (day 5-12) supports the hypothesis 143 
that increasing levels of PDCD4 could repress axon and/or neurite growth. To test this, we 144 
investigated the effect of PDCD4 overexpression on axonal growth following transfection with a 145 
PDCD4 plasmid at day 2 (24 hours after seeding), with analysis of axonal length carried out 72 hours 146 
later (day 5 of cell culture). Before the functional evaluation, we confirmed that neurons transfected 147 
with PDCD4 plasmid have a significant increase in PDCD4 levels detected by immunocytochemistry 148 
(Fig S1A). Increased PDCD4 levels during this period of active axonal growth (days 2-5 in vitro) 149 
produced a significant reduction in axonal length (Fig 2B). To further confirm the dynamic regulation 150 
of axonal growth based on PDCD4 levels, we showed that the siRNA-dependent knockdown of 151 
PDCD4 produced the opposite effect, with a significant increase in axonal length (Fig. 2C). To assess 152 
if this effect was also observed in peripheral neurons, we evaluated axonal growth in dorsal root 153 
ganglia (DRG) neurons cultured in compartmentalized microfluidic chambers. Addition of a cell-154 
permeable siRNA probe targeting PDCD4 produced a significant increase in axonal growth (Fig 2D). 155 
Importantly, we confirmed that in both cortical and DRG neurons the addition of PDCD4 siRNA led to 156 
a significant decrease in PDCD4 levels detected by immunochemistry (Fig. S1B-C), an effect further 157 
confirmed by immunoblotting using the neuroblastoma N2a cell line, which has high transfection 158 
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efficiency (Fig. S1D). Overall, these functional studies demonstrate that PDCD4 modulates axonal 159 
growth in central and peripheral nervous system neurons.  160 
 161 
Ribosome profiling reveals that PDCD4 regulates the translation of genes involved in 162 
axon/neurite growth  163 
To explore the capacity of PDCD4 to regulate translation in neurons we decided to use the ribosome 164 
profiling strategy (Ribo-Seq) in differentiated PC12 neuron-like cells, as a suitable and relevant model 165 
for the investigation of neuronal mechanisms (Shao et al. 2016; Zheng et al. 2016). To confirm the 166 
experimental validity of this approach, we first demonstrated the expression of PDCD4 in PC12 cells 167 
at different time points following NGF-induced neuron differentiation, with levels remaining relatively 168 
stable throughout the culture period (Fig. S2A). Using a doxycycline inducible shRNA system, we 169 
obtained stable cell populations with inducible silencing of PDCD4 expression. In this way, addition 170 
of NGF and doxycycline for 72 hours allowed us to achieve neuron differentiation of PC12 and 171 
silencing of PDCD4 expression (Fig. S2B-G). 172 
 173 
As a first experimental approach to the use of PC12 neuron-like cells, we analysed if neurite growth 174 
was regulated by the presence or absence of PDCD4. Confirming our previous observations in 175 
primary neuron cultures, knockdown of PDCD4 in PC12 cells increased neurite length compared to 176 
controls (Fig 3A-B), allowing us to validate their use in the search for putative PDCD4 translational 177 
targets. For this, we isolated polysomal and total RNA from differentiated PC12 cells in the presence 178 
and absence of PDCD4. Samples were analysed using parallel RNA-Seq and Ribo-Seq protocols 179 
(Fig. S3A-C), which allowed us to determine steady-state transcriptome and translatome levels for 180 
over 10,000 mRNAs (Table S1). Fold changes (shPDCD4/shScrambled) at both transcriptome and 181 
translatome levels were contrasted for detected genes according to their previously described roles 182 
(Matsuhashi et al. 2019), with PDCD4-knockdown having an impact on both transcriptome and 183 
translatome compartments (Fig. 3C-D, Fig. S3D-G and Table 1). To specifically study PDCD4 184 
regulation in protein synthesis, we compared translation efficiency (TE) levels between conditions. 185 
TE, which is calculated as the ratio between translatome over transcriptome levels for a particular 186 
mRNA, is an informative parameter to discriminate translational regulation events from those 187 
exclusively transcriptional, and indicates how efficiently an mRNA is translated (Ingolia et al. 2009). 188 
Using the Xtail R package (Xiao et al. 2016) to explore TE differences, we detected 267 mRNAs 189 
whose TE levels significantly increase following PDCD4 knock-down (p value <0.05; Fig. 3E-F, Fig. 190 
S4, Table 1 and S2), and 100 mRNAs whose TE decreases. The first group, which represents 191 
potential PDCD4 targets, displays unaltered steady-state transcriptome levels (88% has |fold change| 192 
<1.5 fold), but they increase their levels of translation (86% has fold change >1.5 fold; Fig. 3F). In 193 
order to explore if the regulation of translational efficiency was also being observed at the protein 194 
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level, total protein samples obtained at the same time of the sequencing analysis were quantified by 195 
label-free proteomics. Although we observed some specific correlations with Ribo-Seq data, we could 196 
only detect a small fraction of proteins changing significatively, with the sensitivity of this approach 197 
not sufficient to detect global correlations (Fig. S5).  198 
 199 
To investigate the functional implications of PDCD4 regulation over the 267 putative targets that 200 
increase their translational efficiency, protein association analysis was performed using STRING 201 
(Jensen et al. 2009). This revealed 3-4 related and altered protein cores and a network with 202 
significantly more interactions than expected (p value = 0.0163; Fig. S6A). The observed related 203 
protein cores within PDCD4 putative targets are grouped under regulation of mitosis (Moustafa-Kamal 204 
et al. 2019), centromere and kinetochore; regulation of transcription and splicing (Kim et al. 2014) 205 
(see Fig. 3C and Fig. S3D-E); regulation of mitochondrial activity (Zhang et al. 2006); and protein 206 
translocation to the endoplasmic reticulum (Hudson 2008; Wang et al. 2013). Interestingly, when 207 
analysing the list of targets whose translational efficiency decreases in the absence of PDCD4 (100 208 
genes), we found that neither core related proteins nor protein interactions were significantly altered 209 
(p value = 0.954; Fig. S6B). This difference provides a good indication that those putative targets 210 
increasing their translation after PDCD4 knock-down represent a defined set of cellular functions, 211 
while those down-regulated in our sequencing data are likely emerging as a secondary cell effect 212 
and/or experimental noise. 213 
 214 
In order to uncover those potential PDCD4 targets with functional links to neurite, axon and/or 215 
dendritic growth, we curated the list using in-house software that allowed us to link published articles 216 
with gene lists and user-defined terms (manuscript in preparation; 217 
https://github.com/sradiouy/IdMiner). We also explored the list of differentially expressed genes 218 
separately at the transcriptome or translatome level (fold change >2 and p value <0.05 estimated by 219 
edgeR), and the down-regulated genes at TE (100 genes with p value <0.05 estimated by Xtail), 220 
searching for genes that might inhibit neurite outgrowth. This comprehensive approach highlighted 221 
several experimentally validated axon and/or neurite outgrowth related genes from the list of potential 222 
PDCD4 translational targets. This signature of 36 genes was mainly composed of upregulated genes 223 
at the level of TE in PDCD4 absence (26 genes), but also by genes upregulated only at the 224 
translatome (4 genes) or transcriptome levels (3 genes), or downregulated at TE (3 genes) whose 225 
ascribed function is to inhibit neurite outgrowth. Transcriptome and translatome levels of the 36 genes 226 
shows a global induction of translation after PDCD4 knockdown, from low-middle to high translational 227 
levels (Fig. 4A).  228 
 229 
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Among the signature of neurite and axon-growth related genes, we found genes previously reported 230 
to directly control neurite outgrowth: Elavl4, Styxl1, Bdnf, Dmd, Lancl2, Lif and Nfkb2. In the case of 231 
ELAVL4 (also known as HUD), DMD and LANCL1 proteins, their expression is required for neurite 232 
outgrowth in PC12 cells (Mobarak et al. 2000; Fukao et al. 2009; Acosta et al. 2004; Zhang et al. 233 
2009), while the pseudo phosphatase MK-STYX (STYXL1) increases both the number of cells with 234 
neurite extensions and neurite outgrowth in PC12 (Flowers et al. 2014). Brain-derived neurotrophic 235 
factor (BDNF) was shown to increase neurite length in rodent primary neuronal cultures (Iwasaki et 236 
al. 1998; Dajas-Bailador et al. 2012; Cohen-Cory et al. 2010), as well as in PC12 cells (Squinto et al. 237 
1991; Iwasaki et al. 1997). On the other hand, the TE of LIF is down-regulated in PDCD4’s absence, 238 
and it was shown that activating LIF receptor signaling can have a negative impact on neurite 239 
extension in PC12 cells (Ng et al. 2003). Particularly interesting is the relationship between the 240 
transcription factor complex nuclear factor-kappa-B (NFkB) and neuritogenesis, where activating 241 
NFkB pathway and increasing Nfkb2 gene expression promotes neuritogenesis in PC12 cells 242 
(Manecka et al. 2013). This strong link motivated us to confirm PDCD4 regulation of NFKB2 protein 243 
abundance. For this we used a model of cortical neurons in culture, silencing PDCD4 by a new set 244 
of lentiviral particles with shRNA against PDCD4, and quantifying protein abundance by western blot. 245 
By this, we confirmed by an orthogonal method that NFKB2 total protein levels increase significantly 246 
after knockdown of PDCD4 (Fig. S7).  247 
 248 
In line with the notion that PDCD4 can regulate axon-related mRNA translation in neurons, we found 249 
that a significant proportion of the 267 putative translational targets identified in our Ribo-Seq analysis 250 
are found in two different published axonal transcriptomes from in vitro neuron models (Fig. 4B). On 251 
the other hand, those genes for which we observe a decrease in the TE after PDCD4 knock-down, 252 
are not specifically enriched in axonal transcriptomes, providing further support to our hypothesis that 253 
they reflect secondary mechanisms (Fig. S8). A significant fraction of PDCD4 mRNA translational 254 
targets were also found in the recently described in vivo motor axon transcriptome (Farias et al. 2020) 255 
(23 out of 255, in a set of 1008 mRNAs; p value = 2.8E-04). These findings support the idea that 256 
PDCD4 could also be a player in regulating local axonal responses and plastic processes in vivo.  257 
 258 
Sciatic nerve injury in vivo reduces local axonal levels of PDCD4 259 
Our in vitro functional studies and ribosome profiling data support the hypothesis that PDCD4 is a 260 
novel regulator of axonal function. For this reason, we decided to test our findings in vivo, using a 261 
model of axon regeneration, a cellular process where the regulation of axonal protein synthesis is 262 
important (Verma et al. 2005; Huebner and Strittmatter 2009; Gumy et al. 2010). For this, we 263 
performed a full transection of the rat sciatic nerve, using the contralateral nerve as a control for no 264 
injury (Fig. 5A). At 18 hours post injury, when the nerve is in the active regeneration phase, we 265 
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analyzed the levels of PDCD4 along the axoplasm. Our analysis demonstrates that uninjured controls 266 
show no change in the expression of PDCD4 along the axoplasm of the sciatic nerves (Fig. 5B, 267 
confocal images of “Proximal” and “Distal” axonal sections in relation to the cell bodies). However, 268 
we observed a significant decrease of ~30% of PDCD4 axonal levels at the site of injury (“distal injury” 269 
in diagram) when compared to the proximal region of the same nerve segment (Fig. 5B). Importantly, 270 
these changes in PDCD4 levels are not due to an overall loss of protein content at the site of injury, 271 
as the levels of actin and MAG do not change when comparing all conditions (Fig. 5B). These findings 272 
allowed us to conclude that axonal levels of PDCD4 are dynamically decreased at the site of axonal 273 
injury and during the regeneration process.  274 
 275 
The potential role of PDCD4 as a translation regulator in axonal growth would require the existence 276 
of precise molecular pathways controlling its localized expression. In this regard, degradation of 277 
PDCD4 would be able to rapidly promote axon regeneration in the context of nerve injury. Indeed, 278 
concomitant to the decrease in PDCD4 levels at in injured axons, we found a significant increase in 279 
the activated form of p70S6K (phospho-p706SK), which acts as a direct regulator of PDCD4 280 
degradation via the mTOR pathway (Dorrello et al. 2006); Fig. 5C). The tight control of protein levels 281 
in the axoplasm is not only dependent on degradation, but also on localized protein translation (Yoon 282 
et al. 2009; Vuppalanchi et al. 2009; Sahoo et al. 2018). Indeed, PDCD4 mRNA levels are detected 283 
in the axon of peripheral neurons, both in vivo (Farias et al. 2020) and in vitro in our DRG 284 
compartmentalized cultures, where qPCR analysis of RNA extracted from the axon compartment 285 
showed an increase from day 3 to 12 (day 3 Ct value = 25.5 and day 12 Ct value = 23.6) samples. 286 
To test if local translation could control PDCD4 levels in axons, we carried out the Puromycin-287 
Proximity Ligation Assay or Puro-PLA in rat ventral roots in vivo (tom Dieck et al. 2015) to explore 288 
local protein synthesis. Consistent with its dynamic role in the control of axon processes, our results 289 
indicate that PDCD4 can be locally translated in mature non-injured axons (Fig. 5D). Overall, these 290 
results revealed two possible molecular mechanisms for the regulation of PDCD4 levels in mature 291 
axons ex vivo, either via degradation and/or local protein synthesis. 292 
 293 
Discussion  294 
 295 
Our studies demonstrate that PDCD4 is expressed in different neuronal cell types of the CNS and 296 
PNS and is distributed in axonal and dendritic compartments, possibly interacting with other 297 
components of the mTOR pathway, such as its upstream protein regulator p70S6K (Fig. 1). Since 298 
PDCD4 is known to regulate protein synthesis in tumor models and also act as a downstream 299 
component of mTOR pathway, we postulated that it could have a role in molecular processes relevant 300 
to axonal function. The possibility that PDCD4 functions as a translation regulator factor in both 301 
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cancer and neuronal cells agrees with the observation that many of the key cellular hallmarks of 302 
cancer encompass molecular processes that are crucial in nervous system development, such as 303 
invasive cell growth, cytoskeleton rearrangements, ECM dynamic interactions and survival (Duman-304 
Scheel 2009; Heine et al. 2015).  305 
 306 
In mouse primary cortical neurons, we observed that PDCD4 is localized to the cell body and axons, 307 
with levels increasing during time in culture (Fig. 2A). This increase in PDCD4 levels correlates with 308 
neuronal network maturation and the establishment of synaptic contacts, a period that requires 309 
decreased axon growth. It is thus possible that elevated levels of PDCD4 mark the end of active 310 
axonal growth and the establishment of a stable cortical network. Further confirmation came from the 311 
overexpression of PDCD4, which caused a significant decrease in axonal growth. Importantly, the 312 
knockdown of PDCD4 levels caused the opposite effect, with a significant increase in axonal length 313 
(Fig. 2C-D). The analysis of axonal growth in primary cortical neurons constituted a useful approach 314 
for the investigation of the cellular and molecular mechanisms that control neuronal network 315 
development in the CNS. However, the elucidation of those mechanisms that can control axonal 316 
growth is also a fundamental area of research in the study of nerve regeneration in PNS (He and Jin 317 
2016). It was thus important to investigate if PDCD4 could have a role in the regulation of axonal 318 
growth using an in vitro model of peripheral neurons, such as dissociated DRG primary 319 
neurons. Consistent with the high levels of PDCD4 observed in peripheral axons in vivo (Fig. 1B-C), 320 
and the functional data from cortical neurons (Fig. 2B-C), siRNA dependent knockdown of PDCD4 in 321 
DRG neurons grown in microfluidic chambers (Taylor and Jeon 2011; Dajas-Bailador et al. 2012) 322 
showed a significant increase in axon growth (Fig. 2D). Overall, the functional studies in primary 323 
neurons of central and peripheral origin, demonstrate a clear mechanistic link between the control of 324 
PDCD4 levels and the regulation of axon growth and network development, confirming that PDCD4 325 
can modulate these processes, probably at the level of translation.  326 
 327 
In order to explore the molecular signature underlying the link between PDCD4 and the control of 328 
neurite/axon growth, we decided to use a genomic approach to elucidate putative PDCD4 329 
translational targets. To do this, we first generated a stable PC12 cell line able to induce PDCD4 330 
knockdown by shRNA (Fig. S2), and then confirmed that similar to primary neurons, PDCD4 331 
knockdown caused an increase in the neurite length of differentiated PC12 neuron-like cells (Fig. 3A-332 
B). Despite its described role in selective mRNA translational mechanisms, the investigation of 333 
PDCD4 targets has been largely unexplored using genomics approaches, neither in cancer nor in 334 
neuronal models. However, very recent work by Haas and collaborators described PDCD4 targets 335 
using transcriptomics and Ribo-Seq in a telomerase-immortalized human epithelial cell line (Haas et 336 
al. 2020). The implementation of Ribo-Seq protocols, which are based on deep sequencing of 337 
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ribosome-protected mRNA fragments, makes it possible to monitor translation directly, significantly 338 
improving the estimation of protein translation levels as compared to the classic RNA-Seq 339 
approaches (Ingolia et al. 2012; Eastman et al. 2018). Our Ribo-Seq data confirmed the key role of 340 
PDCD4 in the regulation of translation and provided only the second approximation to the full scope 341 
of its cellular targets, and the first in a neuronal cell model (Fig. 3C-F). It allowed us to compare the 342 
PDCD4-dependent transcriptome and translatome data sets (Fig. 3C-D), identifying 267 mRNAs with 343 
a potential role as PDCD4 translational targets (Fig. 3E-F). This set of neuronal-related putative 344 
targets significantly increases their translational efficiency in the absence of PDCD4 (p value <0.05 345 
estimated by Xtail; Table S2). We compared this list with that defined by Haas et al, where 62 mRNAs 346 
increase their translation upon PDCD4 silencing. Although 50 of those 62 targets could be detected 347 
in our study and show considerable expression levels, only Cldnd1, an apoptosis-related gene in 348 
epithelial cells (Achari et al. 2015), is common to both studies. This is likely the reflection of differences 349 
in cell type, developmental stage and experimental model, and provides a tantalising perspective on 350 
the regulatory potential that can be attributed to PDCD4 and which is likely controlled by the additional 351 
recruitment of cell- and stage-specific mechanisms.  352 
In order to further elucidate the regulatory mechanisms at play, samples from the same RNA-Seq 353 
and Ribo-Seq experimental protocols were analysed by label-free quantitative proteomics (LFQ). 354 
However, the number of observed and regulated proteins (~3000 and 141 proteins, respectively) 355 
were lower than expected. From 141 differentially expressed proteins (p value <0.05; ANOVA), 87 of 356 
them (62%) show the same direction of change seen in the Ribo-Seq data (with similarly positive or 357 
negative fold changes, Fig S5B). In addition to the lack of sensitivity, it is also likely that protein levels 358 
might need to be evaluated at later time points than the Ribo-Seq data, but this was beyond the scope 359 
of this study. Ultimately, protein levels are also subject to dynamic regulatory processes that control 360 
their half-life and degradation, and which might prevent the direct correlation of Ribo-Seq data with 361 
estimation of proteome levels, particularly for low expression genes which could be relevant in 362 
PDCD4 function (Kumar et al. 2016; Zubarev 2013).  363 
 364 
Based on our functional results with primary neurons, we investigated the list of potential PDCD4 365 
targets identified from our Ribo-Seq data to uncover a neurite/axon growth gene signature. A list of 366 
36 PDCD4 targets emerged with axon growth and/or neurite outgrowth links (Fig. 4A). Besides the 367 
genes associated with neurite outgrowth in PC12 cells described previously, the remaining genes 368 
were also described as associated with neurite or axonal growth previously in the literature (Chen et 369 
al. 2019; Olbrich et al. 2013; Bali et al. 2013; Kar et al. 2013; Su et al. 2006; Mincheva-Tasheva et al. 370 
2014; Munnamalai et al. 2014; Fiesel et al. 2011; Yu et al. 2016); (Nakanishi et al. 2006; Siddiq et al. 371 
2015; Parviainen et al. 2017; Bisogno et al. 2003; Tang et al. 2017; Ghiani et al. 2010). Relevant and 372 
interesting examples include genes coding for proteins associated with the cytoskeleton, either actin 373 
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with Tmsb4x (van Kesteren et al. 2006; Yang et al. 2008) or microtubules with Stmn3, (Riederer et 374 
al. 1997; Manna et al. 2007); cell adhesion molecules like Cadm1 (Nagara et al. 2012), Amigo2 (Kuja-375 
Panula et al. 2003), Dscaml1 (Hattori et al. 2008; Hutchinson et al. 2014; Zhu et al. 2013), and Emb 376 
(Lain et al. 2009), transmembrane proteins associated to signal transduction including Tspan7, 377 
(Bassani and Passafaro 2012); calcium-binding proteins like Spock3 (Yamamoto et al. 2014; 378 
Schnepp et al. 2005), Hpcal1 (Braunewell et al. 2011; Wang et al. 2014) and Camk2b (Fink et al. 379 
2003; Yan et al. 2016), anterograde and retrograde transport and signaling with mRNAs like Dynll1 380 
(Lin et al. 2015) and Lancl2, different kinases like Tnik (Kawabe et al. 2010), Mob1b, (Lin et al. 2011; 381 
Song et al. 2018), Pnck (Wayman et al. 2004; Uboha et al. 2007) and also synaptic-associated 382 
proteins like Rab3il1 (Villarroel-Campos et al. 2016). Importantly, a significant proportion of PDCD4 383 
putative translational targets identified in our analysis were also found in axonal transcriptomes from 384 
in vitro neuron models (Zappulo et al. 2017; Nijssen et al. 2018) and in vivo motor axon transcriptome 385 
(Farias et al. 2020) (Fig. 4B), supporting the validity of these processes beyond our experimental 386 
models.  387 
 388 
Indeed, our own work managed to extend the observation of PDCD4’s capacity for regulation of axon 389 
growth in primary neurons to an in vivo axon regeneration model, demonstrating that PDCD4 levels 390 
decrease following injury and during the regenerative growth phase (Fig. 5A-B). Taking into 391 
consideration that PDCD4 levels are high along adult peripheral axons in sciatic nerves (Fig. 1B), we 392 
believe a decrease in the levels of this translational repressor would allow the expression of growth-393 
related proteins to aid local axon regeneration. Taken together, our in vitro and in vivo experiments 394 
support the idea that the dynamic control of PDCD4 levels in the neurons and axons could act as a 395 
new regulatory mechanism of protein synthesis in a specific and growth-oriented manner.  396 
 397 
The role proposed for PDCD4 in the regulation of local protein synthesis in neurons would require a 398 
tight control of its levels in the axon. In agreement with previous reports (Verma et al. 2005; Terenzio 399 
et al. 2018) we found that the active form of p70S6K protein (phosphorylated at Thr 389) was 400 
increased 2-fold at the injury site, when compared to uninjured axons (Fig. 5C). Given that the local 401 
activation of the mTOR pathway in the injured axons increases axonal protein synthesis (Verma et 402 
al. 2005; Terenzio et al. 2018), our findings confirm that  the increased phosphorylation of p706SK in 403 
the axons correlates with a decrease in PDCD4 levels, likely mediated by activation of the proteasome 404 
system (Dorrello et al. 2006). In this scenario, the translation repression offered by PDCD4 would be 405 
removed, releasing the potential for growth mechanisms. 406 
 407 
Local depletion of PDCD4 would be useful to mediate a rapid regeneration response, however, local 408 
neo-synthesis can be used as an important mechanism to modulate protein synthesis of specific 409 
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targets in other contexts of neuron development, when axon growth is reduced and synaptic 410 
consolidation might be needed. Indeed, PDCD4 levels have been shown to be regulated by miR-21 411 
in cancer models increasing transformation, invasion and metastasis (Matsuhashi et al. 2019; 412 
Asangani et al. 2008). Consistent with this, miR-21 is up-regulated during axonal growth and 413 
regeneration in DRG axons (Strickland et al. 2011) and miR-21 and PDCD4 have been analyzed in 414 
a model of spinal cord injury, were whole tissue levels of miR-21 increase and PDCD4 decrease after 415 
injury (Jiang et al. 2017). To test the potential existence of local protein synthesis as a regulatory 416 
mechanism controlling PDCD4 protein levels in the axoplasm we used proximity ligation assays (PLA) 417 
(tom Dieck et al. 2015). Our results suggest that PDCD4 is locally translated in the axoplasm of 418 
peripheral neurons (Fig. 5D), supporting previous neurite data of newly synthetized proteomics, 419 
where PDCD4 is also detected (Zappulo et al. 2017).  420 
 421 
Overall, our study shows the expression of PDCD4 in different types of neurons ex vivo, in vitro and 422 
also at different development stages in both mouse and rat experimental models. These results 423 
demonstrate a role of PDCD4 in processes where the dynamic regulation of protein synthesis is of 424 
crucial importance, such as axonal growth, in both development and regeneration. We report the first 425 
Ribo-Seq dataset for PDCD4 in a neuronal model, defining 267 mRNAs that could be regulated by 426 
PDCD4 at the translational level, with a significant number of these being related to neuronal plasticity 427 
and axonal growth processes. The potential relevance of this regulatory capacity for PDCD4 is further 428 
suggested by its regulation by local protein synthesis and/or degradation in peripheral axons. Taken 429 
together our findings uncover a new role for PDCD4 in protein synthesis regulation at neuronal and 430 
specifically axon level. This represents new evidence of the interesting correlation between cancer 431 
and neuronal pathways, especially the ones related to axonal growth and regeneration during injury. 432 
Further studies should elucidate the functional implications of those specific mRNAs regulated by 433 
PDCD4 in neurons, and particularly those acting locally in axons, a process that could provide novel 434 
functional insights in both plasticity and regenerative processes. 435 
 436 
Materials and Methods  437 
 438 
Animals and injury procedures 439 
Sprague Dawley male adult rats (6-9 months old) were used for ex vivo experiments. The 440 
maintenance was made in accordance with international agreements at IIBCE bioterium in 441 
Montevideo, Uruguay. Sciatic nerve transection was performed as in Canclini and collaborators 442 
(Canclini et al. 2014). All the experimental procedures were made according to the Uruguayan ethical 443 
national committee (CNEA) with approved project code “005/01/2014”. 444 
 445 
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Cell Cultures 446 
Rats (Sprague-Dawley) and mice (C57/BL6) used for primary neuron cultures were housed at the 447 
Animal Unit in the School of Life Sciences (University of Nottingham). They were bred and sacrificed 448 
according to the UK Animal (Scientific Procedures) Act 1986. Primary cortical neuron cultures were 449 
obtained from C57/BL6 E16 mice brains as previously described (Lucci et al. 2020). Primary DRGs 450 
cultures were obtained from E18 rat embryos. PC12 cell line from ATCC (ATCC CRL-1721) were 451 
grown in collagen I (ThermoFisher, Cat# A1048301) coated plastic surfaces at 8 μg/cm2. Complete 452 
medium was made of RPMI (ThermoFisher, Cat# 31800022), 10% of horse serum (ThermoFisher, 453 
Cat# 26050088), 5% of fetal bovine serum (Capricorn Scientific, Cat# FBS-11A) and antibiotics 454 
(Sigma-Aldrich, Cat# A5955). The cells were cultured following commercial instructions and neuronal 455 
differentiation was achieved by removing growth factors and antibiotics and exposing cells to 100 456 
ng/mL of NGF 2.5S (ThermoFisher, Cat# 13257019) for at least 72 hrs. Neuroblastoma (Neuro2a) 457 
cell line were a kind gift from Robert Layfield lab, University of Nottingham, UK. For more details 458 
about cell cultures please see supplementary material and methods. 459 
 460 
siRNA and plasmid transfections 461 
Primary cortical neurons and Neuro2a cells were both transfected 24 hours after neuron seeding (day 462 
2 of culture). For siRNA experiments we used 25 nM of siGENOME Mouse Pdcd4 SMARTpool 5 463 
nmol (Cat# M-044032-01-0005) or siGENOME Non-Targeting siRNA Control Pool N°1 5 nmol (Cat# 464 
D-001206-13-05), both from GE Healthcare Dharmacon - Horizon Solutions. Transfection protocols 465 
followed manufacturer's instructions using Lipofectamine 2000 (Invitrogen, ThermoFisher). Plasmid 466 
transfections were performed with 2 µg of PDCD4-pcDNA 3.1 (zeromycin), kindly gifted by Yang Hsin-467 
Sheng, using an empty plasmid as control. Cortical neurons were co-transfected with 1 µg pmax-GFP 468 
Green-cat (ThermoFisher). In the specific case of primary DRG neuron cultures, the cell permeable 469 
Accell SMART POOL Pdcd4 siRNA 5 nmol (Cat# E-097927-00-0005) or Accell Non Targeting Pool 470 
5 nmol (Cat# D-001910-10-05), both from GE Healthcare Dharmacon - Horizon Solutions, were 471 
incubated at 1 µM final concentration in the cell body side of compartmentalized chambers after DRGs 472 
develop neurites. The PC12 cell line was transfected using commercial lentiviral particles from 473 
Dharmacon GE, with an inducible shRNA against PDCD4 (SMARTchoice Inducible Rat PDCD4 PGK-474 
turboGFP shRNA, 100 μL, 10^7 TU/mL; Material# VSR6432-223515627), or shScrambled control 475 
(SMARTchoice Inducible Non-targeting Control PGK/TurboGFP, 50 μL, 10^7 TU/mL; Material# 476 
VSC6580). After transfection, cells were grown in complete medium for 24h and selected with 5 477 
µg/mL of puromycin (P7255, Sigma-Aldrich) for 3-5 days. Cells were then cultured in complete 478 
medium to obtain stable cell lines able to induce silencing of PDCD4 or express a scrambled shRNA 479 
control.  480 
 481 
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Immunohistochemistry and immunocytochemistry 482 
For tissue sections, rats were intracardially perfused with 3% sodium citrate (S4641-500, Sigma-483 
Aldrich) and 4% PFA (158127, Sigma-Aldrich) in Phosphate Buffer Saline (PBS) buffer pH 7.4 (137 484 
mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 2 mM KH2PO4). Following standard cryoprotection and 485 
0.5 % triton X-100 (13444259, ThermoFisher) permeabilization, 20 µm cryosections were made. 486 
Incubation with primary and secondary antibodies was performed in a blocking buffer with 5% NGS 487 
(MERCK, NS02L) overnight at 4°C. The PHEM buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 488 
2 mM MgCl2) was used for washes. For primary neurons and cell lines, cells were rinsed with PBS 489 
buffer and fixed with 4% PFA, 5 mM CaCl2 and 4% sucrose in PBS buffer for 30 minutes (RT), 490 
permeabilized in 0.2% Triton + 10 mM glycine in PBS for 20 minutes (RT) and incubated with 491 
antibodies overnight. Cells were mounted using Vectashield with DAPI (H-1200-10, VectorLabs) or 492 
Pro-Long Gold Antifade (P36930, ThermoFisher) mountant reagents. For a list of antibodies and 493 
probes used, please see Supplementary Material. 494 
 495 
Puro-PLA protocol  496 
Ventral roots were extracted from adult rats and incubated in neurobasal media with puromycin at 497 
300 µM. Then a fixation with 4% PFA for 1 hour was performed and cryosections were made as 498 
described above. The PLA protocol was carried-out according to the manufacturer's instructions of 499 
DuoLink, Sigma using the following reagents:  Duolink® In Situ PLA® Probe Anti-Rabbit PLUS 500 
(Cat#DUO92002-30RXN), Duolink® In Situ PLA® Probe Anti-Mouse MINUS (Cat#DUO92004-501 
30RXN), Duolink® In Situ Detection Reagents FarRed (DUO92013-30RXN). 502 
 503 
Image acquisition and quantification analysis 504 
Neo-cortex, cerebellum, sciatic nerves and PC12 cells images were taken using an LSM confocal 505 
OLYMPUS FV300 with a 60X oil, NA 1.42 objective. For primary cultures, we used an inverted 506 
fluorescent microscope ZEISS axiovert 200M coupled to a CCD camera (Photometrics CoolSnap 507 
MYO). For axonal length images, a 10X air NA 0.3 or 20X air NA 0.8 were used, while 508 
immunofluorescence quantification was done with a 63X oil NA 1.3. For PLA experiments on ventral 509 
roots a LSM confocal ZEISS 800 was used with a 63x oil, NA 1.4. The stacks were always taken at 510 
an ideal μm number between each z plane.  511 
For image quantification the Fiji (Just Image J) tools (Schindelin et al. 2012) and the Neuron_Growth 512 
plugin software developed by Fanti & collaborators at the Universidad Nacional Autónoma de México 513 
(http://www.ifc.unam.mx/ffm/conditions.html) were used. For full details of quantifications methods 514 
see Supplementary Methods. 515 
 516 
Ribosome Profiling 517 
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Cells were treated with 100 mg/µL of cycloheximide (01810, Sigma-Aldrich) for 1 hour at 37°C in the 518 
hood to stop translation before collection of RNA on ice. A Transcriptome sample was separated to 519 
use as total RNA control and submitted to RNA extraction using mirVana isolation kit (ThermoFisher, 520 
Cat# AM1560) and RNA-Seq protocol. At the same time, a proteome sample was separated and 521 
submitted to label-free quantitative proteomics using an LC-MS/MS Orbitrap Fusion. For translatome 522 
samples, cells were lysed and a polysomal pellet was obtained by ultracentrifugation in sucrose 523 
cushion, resuspended and digested with Benzonase (Sigma-Aldrich, Cat# E1014). Ribosomal 524 
footprints were isolated running a denaturalized 15% PAGE 7M urea, cutting the proper band 525 
identified by length (~30nt) and extracting RNA from gel slice. Ribosomal footprints quality and 526 
quantity was checked using 2100 Agilent Bioanalyzer Small RNA Kit and submitted to smallRNA-Seq 527 
protocol. Two biological replicates per condition (shPDCD4 and shScrambled) and per compartment 528 
(transcriptome, translatome and proteome) were obtained. 529 
 530 
Sequencing and bioinformatic analysis 531 
All transcriptome and translatome samples were sequenced in BGI Tech Solutions. Transcriptome 532 
samples were sequenced using RNA-Seq Quantification Library (Normal Library: 2-10 μg) protocol, 533 
with poly(A)+ selection and 20 millions of paired-end (2x100 bp) reads obtained. Translatome 534 
samples were submitted to Small RNA Library (Low-Input Library: 0.2-1 μg) protocol and 40 millions 535 
of single-end reads were obtained. Sequence data is available at the NCBI Sequence Read Archive 536 
(SRA; https://trace.ncbi.nlm.nih.gov/Traces/sra/) under BioProject ID PRJNA611824.  537 
Sequences were mapped using bowtie2 (Langmead and Salzberg 2012) versus curated mRNAs 538 
described in the mouse genome (available at NCBI ftp site). Read counts were estimated by 539 
featureCounts (Liao et al. 2014) and differential gene expression analysis between transcriptomes or 540 
translatomes was done using edgeR (Robinson et al. 2010). Normalized counts were exported and 541 
translational efficiency was calculated and contrasted between conditions (shPDCD4 vs 542 
shScrambled) using Xtail R package (Xiao et al. 2016). Gene lists analysis was performed using the 543 
online free tool STRING (Jensen et al. 2009) and in-house software (manuscript in preparation; 544 
https://github.com/sradiouy/IdMiner).  545 
For comparison between potential PDCD4 translational targets and axonal transcriptomes we used 546 
published axonal RNA-Seq datasets (Zappulo et al. 2017), (Nijssen et al. 2018). Downloaded FASTQ 547 
files were mapped to the Mus musculus genome (GRCm38) with HISAT2 (Kim et al. 2015). StringTie 548 
(Pertea et al. 2015, 2016) was used to assemble and quantify the transcripts. For subsequent analysis 549 
low expression genes were removed (TPM <1). For the comparison, mouse orthologs of the potential 550 
PDCD4 translational targets were used, since all the axonal transcriptomes datasets come from 551 
murine models. The venn diagram was performed with the VennDiagram package of R (Chen H and 552 
Boutros PC). The EASE Score (a modified Fisher Exact p-value) was used to test if axonal 553 
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transcriptomes were enriched in potential PDCD4 translational targets, and specifically those related 554 
with axonal growth. 555 
 556 
Extended protocols and details are available in SI Appendix. 557 
 558 
Supplementary Information 559 
 560 
Supplementary Information is available describing an extended protocols version, Figures S1 to S8 561 
and Tables S1 to S2. 562 
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Figure and Table Legends 579 
 580 
Figure 1. PDCD4 is expressed in dendrites and axons of the central and peripheral nervous system. 581 
(A) Immunohistochemistry assays show the distribution of PDCD4 protein at different types of 582 
neurons including CA1 hippocampal neurons, Purkinje of Cerebellum and cortical neurons of 583 
prefrontal cortex of adult rats. Cell bodies are indicated by filled arrows and axons (or dendrite for 584 
Purkinje neurons) by unfilled arrows (scale bar 20 µm). (B) PDCD4 protein is also detected in 585 
peripheral axons, like sciatic nerves, by immunohistochemistry. The images above correspond to 586 
longitudinal sections and the images below to transversal sections. Examples of axonal regions are 587 
highlighted in white dotted ROIs (scale bar 10 µm). (C) Longitudinal sections of ventral roots. 588 
Examples of axonal regions are highlighted with white dotted ROIs. A partial colocalization between 589 
PDCD4 and p70-S6K signals is detected (scale bar 5 µm).  590 
 591 
Figure 2. PDCD4 axonal levels change during neuron development and modulation of this protein 592 
can control axonal growth. (A) Immunocytochemistry assays show that PDCD4 levels increase during 593 
cortical primary neurons differentiation in vitro (scale bar 20 µm). Cell bodies were indicated by filled 594 
arrows and axons by unfilled arrows. The signal quantification shows that cell bodies and axons have 595 
a significant increase in PDCD4 expression for day 5, and a trend to increase for day 12, always 596 
compared to day 2. (p value (***) ≤0.001, ANOVA test with Post Tukey, error bars: SEM, n=3 597 
independent primary cortical neuron cultures for day 2 and day 5, with 3 technical replicates for each 598 
independent experiment; n=2 for day 12, with 2 technical replicates for each independent 599 
experiment). (B) Co-transfected cortical primary neurons with a GFP plasmid and a PDCD4 plasmid, 600 
or a GFP plasmid and a pcDNA plasmid (scale bar 20 µm). Overexpression of PDCD4 in transfected 601 
neurons at day 5 induce a decrease in axonal length (25%) compared to control condition (p value 602 
(**) ≤0.01, paired test, n=5 independent primary cortical neuron cultures, error bars: SEM). (C) Same 603 
as above but for PDCD4 knockdown using an siRNA for PDCD4 or an siRNA control (scale bar 20 604 
µm). Downregulation of PDCD4 induces an increase in axonal length (18%) compared to the control 605 
condition (p value (**) ≤ 0.01, paired t test, n=6 independent primary cortical neuron cultures, error 606 
bars: SEM) (D) Immunocytochemistry assays with acetylated tubulin in peripheral DRG neurons 607 
cultured in compartmentalized chambers and transfected with a permeable siRNA for PDCD4, or with 608 
a siRNA control (scale bar 500 µm). Quantification of axonal growth shows similar effect as above: 609 
downregulation of PDCD4 determine an increase (24%) of axonal growth increase (p value (*) ≤0.05, 610 
Student’s t test, n=4, error bars: SEM). In all cases the “n” corresponds to independent biological 611 
replicates. 612 
 613 
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Figure 3. Translatome and steady-state transcriptome levels of expression for mRNAs was quantified 614 
genome-wide by Ribo-Seq and RNA-Seq respectively, in absence (shPDCD4) and presence 615 
(shScrambled) of PDCD4 achieved by lentiviral transfection in neuron-like differentiated PC12 cells. 616 
(A) To explore if PDCD4 modulates neurite outgrowth also in differentiated PC12 cell we compared 617 
neurite length in differentiated PC12 growing in presence and absence of PDCD4. Three independent 618 
cultures were contrasted and illustrative fields are shown (scale bar 50 µm). (B) Quantification of 619 
neurite length of (A) is shown and an increase of almost 1.6X in absence of PDCD4 is detected, with 620 
a marginal trend toward significance (p value = 0.052, Student’s t test, n=3 independent cell cultures 621 
with an average of 80 neurites considered by replicate, error bars: SD). (C) Scatter plot showing 622 
PDCD4 regulation at the level of transcriptome evaluated by RNA-Seq. Red and green dots indicate 623 
differentially expressed genes, up- and down-regulated respectively (|fold change| >2 and p value 624 
<0.05 estimated by edgeR). (D) Same as (C) but for PDCD4 regulation at the level of translatome 625 
evaluated by Ribo-Seq. (E) Fold changes (shPDCD4/shScrambled) at transcriptome and translatome 626 
levels are contrasted for detected genes. Possible PDCD4 translational targets are those that present 627 
a significant increase in translational efficiency (p value <0.05 estimated by Xtail), and are indicated 628 
in blue (267 mRNAs). Along the scatter plot, vertical and horizontal histograms show fold change 629 
values distribution estimated by Ribo-Seq and RNA-Seq. (F) RPKM gene expression levels for 630 
PDCD4 translational targets indicated in blue in (E) are shown for the two compartments (RNA-Seq 631 
and Ribo-Seq) in each condition.  632 
 633 
Figure 4. PDCD4 regulates translation of several neurite growth-related genes evidenced by Ribo-634 
Seq and RNA-Seq. The putative PDCD4 targets are present in previously described axonal 635 
transcriptomes. (A) Expression of neurite and axon growth-related genes is represented by a 636 
heatmap, where an induced expression at translation level is detected in the absence of PDCD4. (B) 637 
Venn diagram showing the intersection between the potential PDCD4 targets and axonal 638 
transcriptomes derived from mESc (Zappulo et al., 2017 and Nijssen et al., 2018). Separate and 639 
overlapping expressions between samples are shown. Only transcripts with a level of expression of 640 
TPM ≥ 1 were considered. The table shows the type of neuron used in each study, the total genes 641 
detected and the number of common genes between potential PDCD4 targets (or potential PDCD4 642 
targets related to axonal growth) and each axonal transcriptome. The EASE Score (a modified Fisher 643 
Exact p-value) is also shown, which indicates gene-enrichment.  644 
 645 
Figure 5. Sciatic nerve injury induces a decrease of PDCD4 levels locally in axons next to the injury 646 
site and an up-regulation (and activation) of p-p70S6K, a component of mTOR-PDCD4 pathway. 647 
PDCD4 could be locally synthetized in peripheral axons as a possible mechanism for protein level 648 
regulation. (A) A complete transection of the sciatic nerve was performed in adult rats using the 649 
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contralateral nerve as a control condition. The analyzed regions are labeled as proximal and distal 650 
(or distal injury) in reference to cell bodies. (B) 18 hours post injury the sciatic nerves were extracted 651 
from the animals and the levels of PDCD4 were analyzed by immunohistochemistry (scale bar 5 µm). 652 
Signal quantification shows no differences on PDCD4 levels between regions in the control condition 653 
(distal vs proximal), but in the injury sciatic nerves a significant decrease on PDCD4 levels at the 654 
injury region was detected (distal injury vs proximal). These changes are specific to PDCD4 because 655 
other proteins in the axon like F-Actin (evidenced by phalloidin) and MAG protein didn't have 656 
differences on expression levels comparing distal injury vs proximal (p value (**) ≤0.01, two tailed 657 
Mann Whitney test, n=3, error bars: SEM). White dotted ROIs correspond to examples of quantified 658 
axonal regions (C) As in (B), levels of PDCD4 and p70S6K were analyzed by immunohistochemistry 659 
comparing injury axons vs control (scale bar 10 µm). By signal quantification we detect an increase 660 
in the phosphorylated form of p70S6K, a direct upstream regulator of PDCD4 expression on mTOR 661 
pathway (p value (***) ≤0.001, two tailed Mann Whitney test, n=2, error bars: SEM). White dotted 662 
ROIs correspond to examples of axonal quantified regions. (D) Maximum intensity projection images 663 
showing Puro-PLA signal for PDCD4 inside the axoplasm at 30 minutes of puromycin incubation and 664 
the associated control condition without puromycin. The green spots inside the axoplasm reveals that 665 
PDCD4 is newly synthetized in the axon. The right panel shows the signal quantification at 2 different 666 
times points of puromycin incubation compared to the control (p value (***) ≤0.001 and p value (*) 667 
≤0.02, ANOVA and Mann Whitney test, n=2, error bars: SEM). White dotted regions define the limits 668 
of the axoplasm region. Note that in all the cases “n” are from independent biological replicates.  669 
 670 
Table 1. Number of analyzed and differentially expressed genes (p value <0.05) estimated by edgeR 671 
for transcriptome and translatome, and by Xtail for translational efficiency.  672 
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